DivestmentApr 20, 2026, 05:31 PM
AnaptysBio Completes Spin-Off of First Tracks Biotherapeutics
AI Summary
AnaptysBio, Inc. completed the previously announced spin-off of First Tracks Biotherapeutics, Inc. on April 20, 2026. The separation was achieved through a pro rata distribution, with AnaptysBio shareholders receiving one share of First Tracks Biotherapeutics common stock for every one share of AnaptysBio common stock held on the April 6, 2026 record date. First Tracks Biotherapeutics' shares began trading on the Nasdaq Stock Market LLC under the ticker symbol "TRAX" on the distribution date.
Key Highlights
- AnaptysBio completed the spin-off of First Tracks Biotherapeutics on April 20, 2026.
- Shareholders received one share of First Tracks Biotherapeutics for each AnaptysBio share.
- The record date for the distribution was April 6, 2026.
- First Tracks Biotherapeutics began trading on Nasdaq under the ticker symbol "TRAX".